留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

山东丘陵农村老年人群硒摄入水平与高血压关系的研究

卢晓地 吕实波 王秀红 王园园 李为波 董淑瑶 石峰 种冠峰

卢晓地, 吕实波, 王秀红, 王园园, 李为波, 董淑瑶, 石峰, 种冠峰. 山东丘陵农村老年人群硒摄入水平与高血压关系的研究[J]. 中华全科医学, 2025, 23(7): 1239-1243. doi: 10.16766/j.cnki.issn.1674-4152.004106
引用本文: 卢晓地, 吕实波, 王秀红, 王园园, 李为波, 董淑瑶, 石峰, 种冠峰. 山东丘陵农村老年人群硒摄入水平与高血压关系的研究[J]. 中华全科医学, 2025, 23(7): 1239-1243. doi: 10.16766/j.cnki.issn.1674-4152.004106
LU Xiaodi, LYU Shibo, WANG Xiuhong, WANG Yuanyuan, LI Weibo, DONG Shuyao, SHI Feng, CHONG Guanfeng. The correlation between selenium intake and hypertension among rural eldly in Shandong Hilly Region[J]. Chinese Journal of General Practice, 2025, 23(7): 1239-1243. doi: 10.16766/j.cnki.issn.1674-4152.004106
Citation: LU Xiaodi, LYU Shibo, WANG Xiuhong, WANG Yuanyuan, LI Weibo, DONG Shuyao, SHI Feng, CHONG Guanfeng. The correlation between selenium intake and hypertension among rural eldly in Shandong Hilly Region[J]. Chinese Journal of General Practice, 2025, 23(7): 1239-1243. doi: 10.16766/j.cnki.issn.1674-4152.004106

山东丘陵农村老年人群硒摄入水平与高血压关系的研究

doi: 10.16766/j.cnki.issn.1674-4152.004106
基金项目: 

山东省医药卫生科技发展计划项目 202312071345

详细信息
    通讯作者:

    种冠峰,E-mail: cgffriends@126.com

  • 中图分类号: R589.9 R544.1

The correlation between selenium intake and hypertension among rural eldly in Shandong Hilly Region

  • 摘要:   目的  调查山东丘陵地区农村老年人群硒摄入量与高血压患病情况,探讨硒摄入水平与高血压的相关性,为制定适宜的高血压防治策略提供依据。  方法  于2023年2—11月采用多阶段分层抽样的方法,在山东丘陵地区13个县(市、区)抽取≥60周岁常住居民进行问卷调查和体格检查,利用膳食摄入量调查表,对调查对象进行近1年的回顾性膳食调查,计算每日硒摄入量,根据硒摄入量五分位数分为5组并进行χ2检验,对高血压危险因素行logistic回归分析。  结果  共调查2 068人,高血压病患者1 153人,高血压患病率为55.75%,标化患病率为58.46%。5组间高血压患病率差异有统计学意义(P<0.05),按照性别、年龄、饮酒、BMI、腹型肥胖、糖尿病、每周运动量分组,不同人群高血压患病率不同(P<0.05)。Logistic回归分析显示,以硒摄入量第1五分位组作为对照,第2五分位组、第3五分位组、第4五分位组、第5五分位组OR值(95% CI)分别为0.945(0.903~1.051)、0.917(0.873~0.945)、0.891(0.854~0.939)、0.832(0.783~0.884),随着每日硒摄入量的增加,OR值呈递减趋势。  结论  硒摄入水平与老年人群高血压患病率呈负相关关系,增加硒摄入量可降低高血压的发病风险。

     

  • 表  1  不同年龄与硒摄入量人群分布情况(人)

    Table  1.   Distribution of selenium intake across different age groups

    年龄(岁) 第1五分位组(9.83~28.31 μg/d) 第2五分位组(28.32~38.75 μg/d) 第3五分位组(38.76~45.91 μg/d) 第4五分位组(45.92~56.23 μg/d) 第5五分位组(56.24~71.54 μg/d) 合计
    60~ 181 183 187 185 194 930
    70~ 142 144 145 151 142 724
    80~ 90 87 82 79 76 414
    合计 413 414 414 415 412 2 068
    下载: 导出CSV

    表  2  高血压患病影响因素的单因素分析

    Table  2.   Univariate analysis of factors influencing hypertension

    变量 调查数 患病率(%) χ2 P
    性别 4.162 0.041
      男性 956 556(58.16)
      女性 1 112 597(53.69)
    年龄(岁) 7.334 0.026
      60~69 930 493(53.01)
      70~79 724 408(56.35)
      ≥80 414 252(60.87)
    吸烟情况 2.901 0.089
      是 623 365(58.59)
      否 1 445 788(54.53)
    饮酒情况 8.968 0.003
      是 497 306(61.57)
      否 1 571 847(53.91)
    BMI 13.727 0.001
      BMI<24 952 492(51.68)
      24≤BMI<28 744 430(57.80)
      28<BMI 372 231(62.10)
    腹型肥胖 9.541 0.002
      是 862 515(59.74)
      否 1 206 638(52.90)
    糖尿病 24.356 < 0.001
      是 365 246(67.39)
      否 1 703 907(53.26)
    每周运动时间(h) 13.029 0.001
      <0.5 452 280(61.95)
      0.5~1.5 643 367(57.08)
      >1.5 973 506(52.00)
    硒摄入量(μg/d) 11.224 0.024
      第1五分位组 413 252(61.02)
      第2五分位组 414 240(57.97)
      第3五分位组 414 233(56.28)
      第4五分位组 415 219(52.77)
      第5五分位组 412 209(50.73)
    下载: 导出CSV

    表  3  不同硒摄入组高血压患病率比较

    Table  3.   Comparison of hypertension prevalence among different selenium intake groups

    组合 组1 组2 χ2 P
    1 第1五分位组 第2五分位组 0.675 0.411
    2 第1五分位组 第3五分位组 1.722 0.189
    3 第1五分位组 第4五分位组 5.407 0.020
    4 第1五分位组 第5五分位组 8.443 0.004
    5 第2五分位组 第3五分位组 0.178 0.674
    6 第2五分位组 第4五分位组 2.062 0.151
    7 第2五分位组 第5五分位组 4.079 0.043
    8 第3五分位组 第4五分位组 0.893 0.345
    9 第3五分位组 第5五分位组 2.340 0.126
    10 第4五分位组 第5五分位组 0.269 0.604
    注:校正检验水准α=0.005。
    下载: 导出CSV

    表  4  高血压患病影响因素的多因素logistic回归分析

    Table  4.   Multivariate logistic regression analysis of factors influencing hypertension

    变量 B SE Waldχ2 P OR 95% CI
    性别
      男性 0.182 0.089 4.182 0.041 1.199 1.007~1.428
    年龄(岁)
      70~79 0.869 0.112 60.201 <0.001 2.386 2.827~1.834
      ≥80 1.506 0.063 571.438 <0.001 4.507 3.926~5.034
    吸烟情况
      吸烟 0.156 0.103 2.294 0.122 1.169 0.960~1.423
    饮酒情况
      饮酒 0.147 0.089 2.728 0.091 1.158 0.923~1.313
    BMI
      24~28 0.704 0.128 30.250 <0.001 2.023 1.578~2.614
      ≥28 1.338 0.083 260.497 <0.001 3.813 3.252~4.503
    腹型肥胖
      有 1.146 0.093 151.846 <0.001 3.144 2.587~3.722
    糖尿病
      有 1.266 0.086 216.706 <0.001 3.548 2.929~4.106
    运动时间(h/周)
      0.5~1.5 -0.081 0.019 18.175 <0.001 0.923 0.891~0.960
      >1.5 -0.127 0.031 16.784 <0.001 0.881 0.832~0.936
    硒摄入量(μg/d)
      第2五分位组 -0.056 0.038 2.172 0.144 0.945 0.903~1.051
      第3五分位组 -0.087 0.021 17.163 < 0.001 0.917 0.873~0.945
      第4五分位组 -0.115 0.024 22.960 < 0.001 0.891 0.854~0.939
      第5五分位组 -0.184 0.031 35.229 < 0.001 0.832 0.783~0.884
    注:赋值方法如下,女性=0,男性=1;年龄60~69岁=0,70~79岁=1,≥80岁=2;不吸烟=0,吸烟=1;不饮酒=0,饮酒=1;BMI<24=0,BMI 24~28=1,BMI≥28=2;无腹型肥胖=0,腹型肥胖=1;无糖尿病=0,糖尿病=1;运动时间(h/周)<0.5=0,0.5~1.5=1,>1.5=2;硒摄入量,第1五分位组=0,第2五分位组=1,第3五分位组=2,第4五分位组=3,第5五分位组=4。各变量均以赋值为0的类别为参照组。
    下载: 导出CSV
  • [1] MILLS K T, BUNDY J D, KELLY N, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries[J]. Circulation, 2016, 134(6): 441-450. doi: 10.1161/CIRCULATIONAHA.115.018912
    [2] THOMAS U, CLAUDIO B, FADI C, et al. 2020 International society of hypertension global hypertension practice guidelines[J]. Hypertension, 2020, 75(6): 1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
    [3] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56.

    Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al. Chinese guidelines for the prevention and treatment of hypertension (Revised in 2018)[J]. Chinese Journal of Cardiovascular Medicine, 2019, 24(1): 24-56.
    [4] KAROLINA C, MALGORZATA P, ADAM P, et al. Association between serum selenium concentration and OPG/RANKL/RANK axis in patients with arterial hypertension[J]. Cardiovasc Toxicol, 2022, 22(7): 620-630. doi: 10.1007/s12012-022-09741-x
    [5] MOHAMMADIFARD N, HUMPHRIES K H, GOTAY C, et al. Trace minerals intake: risks and benefits for cardiovascular health[J]. Crit Rev Food Sci Nutr, 2019, 59(8): 1334-1346. doi: 10.1080/10408398.2017.1406332
    [6] PAWEL G, MALGORZATA P, LIDIA J, et al. The total antioxidant status, serum selenium concentrations and the ultrasound assessment carotid intima media thickness in patients with arterial hypertension[J]. Antioxidants, 2021, 10(1). DOI: 10.3390/antiox10010063.
    [7] 杨月欣. 中国食物成分表[M]. 6版. 北京: 北京大学医学出版社, 2018: 27-126.

    YANG Y X. Chinese food composition list[M]. Sixth edition. Beijing: Peking University Medical Press, 2018: 27-126.
    [8] 周晓丽, 刘曼玲, 焦艳会. 多种慢性病管理模式在社区老年高血压患者中的综合应用与评价[J]. 中华全科医学, 2020, 18(3): 449-453. doi: 10.16766/j.cnki.issn.1674-4152.001270

    ZHOU X L, LIU M L, JIAO Y H. Comprehensive application and evaluation of multiple chronic disease management models in elderly patients with hypertension in community[J]. Chinese Journal of General Practice, 2020, 18(3): 449-453. doi: 10.16766/j.cnki.issn.1674-4152.001270
    [9] 中国老年2型糖尿病防治临床指南编写组, 中国老年医学学会老年内分泌代谢分会, 中国老年保健医学研究会老年内分泌与代谢分会, 等. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中华内科杂志, 2022, 61(1): 12-50.

    Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society, et al. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 Edition)[J]. Chinese Journal of Internal Medicine, 2022, 61(1): 12-50.
    [10] 黄文博, 冯娴, 姚元龙, 等. 全科医学视角下我国高血压患者的自我管理[J]. 中华全科医学, 2022, 20(7): 1085-1088. doi: 10.16766/j.cnki.issn.1674-4152.002529

    HUANG W B, FENG X, YAO Y L, et al. Self-management of hypertensive patients in China from the perspective of general practice[J]. Chinese Journal of General Practice, 2022, 20(7): 1085-1088. doi: 10.16766/j.cnki.issn.1674-4152.002529
    [11] SUNDE R A, ZEMAITIS E T, BLINK A B, et al. Impact of glutathione peroxidase-1 (Gpx1) genotype on selenoenzyme and transcript expression when repleting selenium-deficient mice[J]. Biol Trace Elem Res, 2018, 186(1): 174-184. doi: 10.1007/s12011-018-1281-6
    [12] AL-MUBARAK A A, VAN DER MEER P, BOMER N. Selenium, selenoproteins, and heart failure: current knowledge and future perspective[J]. Curr Heart Fail Rep, 2021, 18(3): 122-131. doi: 10.1007/s11897-021-00511-4
    [13] WANG S, YAN R, WANG B, et al. The functional analysis of selenium-related genes and magnesium-related genes in the gene expression profile microarray in the peripheral blood mononuclear cells of Keshan Disease[J]. Biol Trace Elem Res, 2019, 192(1): 3-9. doi: 10.1007/s12011-019-01750-2
    [14] 陈芝君, 马建, 唐娜, 等. 帕金森病发病风险与体内硒元素水平的meta分析[J]. 现代医药卫生, 2022, 38(7): 1144-1149.

    CEHN Z J, MA J, TANG N, et al. Risk of Parkinson's disease and selenium level in vivo: a meta-analysis[J]. Journal of Modern Medicine & Health, 2022, 38(7): 1144-1149.
    [15] LEI L F, ZHANG F W, HUANG J, et al. Selenium deficiency causes hypertension by increasing renal AT1 receptor expression via GPX1/H2O2/NF-κB pathway[J]. Free Radic Biol Med, 2023, 200(9): 59-72.
    [16] 张磊, 张桂娟. 膳食中硒的摄入与高血压疾病相关性的研究进展[J]. 食品安全质量检测学报, 2020, 11(18): 6482-6486.

    ZHANG L, ZHANG G J. Research progress on the correlation between dietary selenium intake and hypertension diseases[J]. Journal of Food Safety and Quality, 2020, 11(8): 6482-6486.
    [17] WAGN L L, GUO L W. Relationship between serum selenium levels and hypertension: findings from the national health and nutrition examination survey, 2009-2018[J]. Cardiovasc Innov App, 2024, 9(1): 1-10.
    [18] VINCETI M, CHAWLA R, FILIPPINI T, et al. Blood pressure levels and hypertension prevalence in a high selenium environment: results from a cross-sectional study[J]. Nutr Metab Cardiovasc Dis, 2019, 29(4): 398-408. doi: 10.1016/j.numecd.2019.01.004
    [19] BASTOLAL M M, LOCATIS C, MAISIAK R, et al. Selenium, copper, zinc and hypertension: an analysis of the national health and nutrition examination survey (2011-2016)[J]. BMC Cardiovasc Disord, 2020, 20(1): 45. DOI: 10.1186/s12872-020-01355-x.
    [20] WANG Z, LIN T F, WEI Y P, et al. A cross-sectional study of the distribution patterns and potential determinants in plasma selenium status among Chinese adults with hypertension[J]. Front Nutr, 2022, 9: 882309. DOI: 10.3389/fnut.2022.882309.
    [21] WU Y L, YU Z L. Association between dietary selenium intake and the prevalence of hypertension: results from the national health and nutrition examination survey 2003-2018[J]. Front Immunol, 2024, 15: 1338745. DOI: 10.3389/fimmu.2024.1338745.
    [22] 何梦洁, 苏丹婷, 邹艳, 等. 浙江省居民膳食硒摄入水平与高血压的关系研究[J]. 预防医学, 2019, 31(1): 5-9.

    HE M J, SU D T, ZOU Y, et al. Association between dietary selenium intake and hypertension in Zhejiang residents[J]. China Preventive Medicine Journal, 2019, 31(1): 5-9.
    [23] 黎祺, 魏捷, 吴欣锐, 等. 中老年人膳食硒与高血压关系的横断面研究[J]. 中华疾病控制杂志, 2017, 21(3): 219-222.

    LI Q, WEI J, WU X R, et al. Cross-sectional study on the relationship between dietary selenium intake and hypertension[J]. Chinese Journal of Disease Control & Prevention, 2017, 21(3): 219-222.
    [24] XIE C X, XIAN J L, ZENG M, et al. Trajectory of selenium intake and hypertension: a 20-year cohort study[J]. Nutrients, 2021, 13(5): 1501. DOI: 10.3390/nu13051501.
    [25] WU G R, LI Z, YANG X M, et al. Cross-sectional study: relationship between serum selenium and hypertension in the Shandong province of China[J]. Biol Trace Elem Res, 2018, 185(2): 295-301. doi: 10.1007/s12011-018-1272-7
  • 加载中
表(4)
计量
  • 文章访问数:  6
  • HTML全文浏览量:  4
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-04-09
  • 网络出版日期:  2025-10-25

目录

    /

    返回文章
    返回